51ÊÓƵ

Media Advisory  Wednesday, May 30, 2018

51ÊÓƵ hosts meeting on chronic pain and the opioid crisis

Event will highlight the need for better pain management and the latest research in the field.

What

On May 31^st and June 1^st  2018, researchers from around the United States will gather at the 51ÊÓƵ for a two-day symposium called . Chronic pain is a major public health problem affecting at least 25 million Americans every day, and over-prescribing of opioids for its treatment has contributed to the current crisis. The crisis highlights the challenges the pain field faces as it tries to develop better treatment and management strategies for patients and health professionals.

At the meeting, convened by the , 51ÊÓƵ Director Francis S. Collins, M.D., Ph.D., and U.S. Surgeon General VADM Jerome M. Adams, M.D. M.P.H., will discuss these challenges and how the 51ÊÓƵ’s Helping to End Addiction Long-term (HEAL) Initiative will help researchers tackle some of them.

Keynote speaker, Judith Paice, Ph.D., R.N., director of the Cancer Pain Program at Northwestern University, and George Carter, a sickle cell patient and advocate, will present their views on the issue. In addition, the meeting will be an opportunity to hear from and talk to researchers and 51ÊÓƵ leaders who address some critical questions for the field:

How can the field make quality pain care available to everyone?

Research has shown that some racial and socioeconomic groups are more vulnerable to poor quality pain management. Eliseo J. Peréz-Stable, M.D., director, 51ÊÓƵ’s National Institute on Minority Health and Health Disparities, will moderate a session on the latest research on racial and socioeconomic disparities in clinical pain management.

What is the link between pain and opioid addiction?

Rita Valentino, Ph.D., director of the Division of Neuroscience and Behavior in 51ÊÓƵ’s National Institute on Drug Abuse, will lead a session in which pain researchers present their studies on the biological links between pain and addiction.

Can cutting-edge brain science improve pain care?

Walter J. Koroshetz, M.D., director of the 51ÊÓƵ’s National Institute of Neurological Disorders and Stroke, will describe how the is supporting research to both understand the neural circuits underlying pain and develop novel treatments.

Who

The following 51ÊÓƵ experts will be available for interviews.

• Francis S. Collins, M.D., Ph.D., director, National Institutes of Health
• Jerome M. Adams M.D., M.P.H., U.S. Surgeon General
• Linda L. Porter, Ph.D., director, 51ÊÓƵ Office of Pain Policy
• Patricia A. Grady, Ph.D., RN, FAAN, director, National Institute of Nursing Research
• Walter J. Koroshetz, M.D., director, National Institute of Neurological Disorders and Stroke
• Ann O'Mara, Ph.D., RN, FAAN, head of palliative research, Division of Cancer Prevention, National Cancer Institute
• Eliseo J. Peréz-Stable, M.D., director, National Institute on Minority Health and Health Disparities
• David Shurtleff, Ph.D., acting director, National Center for Complementary and Integrative Health
• Martha J. Somerman, D.D.S., Ph.D., director, National Institute of Dental and Craniofacial Research
• Rita Valentino, Ph.D., director, Division of Neuroscience and Behavior, National Institute on Drug Abuse
• Nora D. Volkow, M.D., director, National Institute on Drug Abuse

For media inquiries, please contact the NINDS press team at nindspressteam@ninds.nih.gov; 301-496-5751

When

May 31 - June 1, 2018, starting at 8:30 a.m.; Masur Auditorium and FAES Terrace in the 51ÊÓƵ Clinical Center, Building 10, 51ÊÓƵ Campus, 10 Center Drive, Bethesda, Maryland.

For schedules and logistics: 

All talks and panel discussions will be livestreamed via 51ÊÓƵ’s videocast website:

The 51ÊÓƵ Pain Consortium was established to enhance pain research and promote collaboration among researchers across the many 51ÊÓƵ Institutes and Centers that have programs and activities addressing pain. The consortium supports initiatives, development of research resources and tools, and hosts events to promote collaboration and highlight advances in pain research. For more information on the Pain Consortium, please visit .

About the National Institutes of Health (51ÊÓƵ): 51ÊÓƵ, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. 51ÊÓƵ is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about 51ÊÓƵ and its programs, visit www.nih.gov.

51ÊÓƵ…Turning Discovery Into Health^®

More Information